Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptor-binding activities

被引:69
作者
Kannan, Thirumalai R. [1 ]
Krishnan, Manickam [1 ]
Ramasamy, Kumaraguruparan [1 ]
Becker, Argentina [2 ]
Pakhomova, Olga N. [2 ]
Hart, P. John [2 ,3 ]
Baseman, Joel B. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Ctr Airway Inflammat Res, Dept Microbiol & Immunol, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA
[3] South Texas Vet Hlth Care Syst, Dept Vet Affairs, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA
关键词
TOXIGENIC ESCHERICHIA-COLI; PROTEIN HOMOLOGY DETECTION; SITE-DIRECTED MUTAGENESIS; HEAT-LABILE ENTEROTOXIN; CHOLERA-TOXIN; PERTUSSIS TOXIN; HELICOBACTER-PYLORI; RIBOSYLATING TOXINS; ASTHMA; INFECTIONS;
D O I
10.1111/mmi.12680
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Community-acquired respiratory distress syndrome (CARDS) toxin from Mycoplasma pneumoniae is a 591-amino-acid virulence factor with ADP-ribosyltransferase (ADPRT) and vacuolating activities. It is expressed at low levels during in vitro growth and at high levels during colonization of the lung. Exposure of experimental animals to purified recombinant CARDS toxin alone is sufficient to recapitulate the cytopathology and inflammatory responses associated with M. pneumoniae infection in humans and animals. Here, by molecular modelling, serial truncations and site-directed mutagenesis, we show that the N-terminal region is essential for ADP-ribosylating activity. Also, by systematic truncation and limited proteolysis experiments we identified a portion of the C-terminal region that mediates toxin binding to mammalian cell surfaces and subsequent internalization. In addition, the C-terminal region alone induces vacuolization in a manner similar to full-length toxin. Together, these data suggest that CARDS toxin has a unique architecture with functionally separable N-terminal and C-terminal domains.
引用
收藏
页码:568 / 581
页数:14
相关论文
共 52 条
[1]
Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections [J].
Atkinson, Thomas Prescott ;
Balish, Mitchell F. ;
Waites, Ken B. .
FEMS MICROBIOLOGY REVIEWS, 2008, 32 (06) :956-973
[2]
Baseman J B, 1993, Subcell Biochem, V20, P243
[3]
Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections [J].
Baseman, JB ;
Reddy, SP ;
Dallo, SF .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :S137-S144
[4]
Mycoplasma antigens as a possible trigger for the induction of antimitochondrial antibodies in primary biliary cirrhosis [J].
Berg, Christoph P. ;
Kannan, Thirumalai R. ;
Klein, Reinhild ;
Gregor, Michael ;
Baseman, Joel B. ;
Wesselborg, Sebastian ;
Lauber, Kirsten ;
Stein, Gerburg M. .
LIVER INTERNATIONAL, 2009, 29 (06) :797-809
[5]
Mycoplasma pneumoniae and asthma in children [J].
Biscardi, S ;
Lorrot, M ;
Marc, E ;
Moulin, F ;
Boutonnat-Faucher, B ;
Heilbronner, C ;
Iniguez, JL ;
Chaussain, M ;
Nicand, E ;
Raymond, J ;
Gendrel, D .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (10) :1341-1346
[6]
SITE-SPECIFIC MUTAGENESIS OF THE CATALYTIC SUBUNIT OF CHOLERA-TOXIN - SUBSTITUTING LYSINE FOR ARGININE-7 CAUSES LOSS OF ACTIVITY [J].
BURNETTE, WN ;
MAR, VL ;
PLATLER, BW ;
SCHLOTTERBECK, JD ;
MCGINLEY, MD ;
STONEY, KS ;
ROHDE, MF ;
KASLOW, HR .
INFECTION AND IMMUNITY, 1991, 59 (11) :4266-4270
[7]
PERTUSSIS TOXIN S1 MUTANT WITH REDUCED ENZYME-ACTIVITY AND A CONSERVED PROTECTIVE EPITOPE [J].
BURNETTE, WN ;
CIEPLAK, W ;
MAR, VL ;
KALJOT, KT ;
SATO, H ;
KEITH, JM .
SCIENCE, 1988, 242 (4875) :72-74
[8]
COVER TL, 1992, J BIOL CHEM, V267, P10570
[9]
Molecular Mechanisms of the Cytotoxicity of ADP-Ribosylating Toxins [J].
Deng, Qing ;
Barbieri, Joseph T. .
ANNUAL REVIEW OF MICROBIOLOGY, 2008, 62 :271-288
[10]
Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages [J].
Domenighini, M ;
Rappuoli, R .
MOLECULAR MICROBIOLOGY, 1996, 21 (04) :667-674